Application is now open for the online training course on working with the media, by the Rights Reporter Foundation (Drugreporter).

Application is now open for the online training course on video advocacy, by the Rights Reporter Foundation (Drugreporter). 

Cannabis legalization is coming to Europe: the governments of Luxembourg and Switzerland announced their plan to regulate the production and sale of cannabis products, other countries may follow their lead soon. What do drug policy professionals and activists think about this? We asked a couple of experts to comment, pro and con. We publish their views without editing.

Robert Veverka, an activist, a politician and the editor of the most popular Czech cannabis magazine, Legalizace, is being prosecuted for “inciting and promoting toxicomania.” Read our interview with him.

DUNews, together with Talking Drugs, presents the first episode of Drug Policy and Harm Reduction News from Eastern Europe and Central Asia. In it, we bring you up to date on important developments in our countries and give the floor to experts for comment. We will be publishing these video newsletters on a regular basis.

The Harm The Key Principles of Harm Reduction are an innovative set of tools developed through the HR4Homelessness Project. The innovation lies in their capacity to translate existing experiences and knowledge on Harm Reduction into actionable guidance through an open, iterative and evolving framework.

The mass detention and forced treatment of people who use drugs in Afghanistan reminds us of the darkest periods of history.

Drug policy news from around the world, October episode.

An organisation of progressive young people, The Dignity Movement, is fighting for a more inclusive and supportive drug policy in Armenia. We interviewed the president of the organisation, Ashot Gevorgyan.

On July 6th 2021, our close friend, colleague, and world-renowned addictologist Tomáš Zábranský left us. This text, written by his friend and well-known cannabis activist Jindřich Bayer, is dedicated to him. It asks the question, how did it all start? What was the context for Tomas’ decision to contribute to reforming drug policy on a global level?